The company provided updates for its study programs for 2024, with a focus on its glucagon-like peptide-1 (“GLP-1”) agonist research…
ECGI Holdings is targeting a share of the growing luxury goods market by designing, manufacturing, and selling luxury equestrian apparel…
HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced a strategic partnership with RxSpark, a platform dedicated to providing…
Upstream, a MERJ Exchange stock market and global trading app, is powered by blockchain technology, which is self-sufficient and operates…
Clene has conducted five Phase 2 clinical trials, three with long-term extensions, and three expanded access programs (with additional studies…
Domestic violence worldwide is fostering a concerted response by criminal justice officials and legislators upset by the deadly fallout of…
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and…
U.S. Patent No. 12,042,482 specifically addresses traumatic brain injury (“TBI”) treatment with buntanetap, enhancing Annovis Bio’s portfolio that includes various…
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and…
Alphabet (NASDAQ: GOOGL, GOOG), the parent company of Google, is currently facing a challenging period, with antitrust scrutiny at the…